LongevityGLEI / 2016
Longevity Science / 15 December 2016
Partial reprogramming opens a new research direction
A Salk study reported changes in aging markers in cells and a premature-aging mouse model.
Read the analysis ↗GLEI / RESEARCH
Longevity Science
Exploring the science, economics and human potential of longevity. Independent perspectives for a healthier, more equitable future.
From cellular mechanisms to carefully evaluated interventions.
LongevityGLEI / 2024
Longevity Science / 18 December 2024
FDA approves its first mesenchymal stromal cell therapy
Ryoncil's approval concerns a specific pediatric graft-versus-host disease indication.
Read the analysis ↗LongevityGLEI / 2022
Longevity Science / 07 March 2022
Partial reprogramming is studied in normally ageing mice
Researchers examined longer treatment schedules and molecular changes in ageing animals.
Read the analysis ↗LongevityGLEI / 2019
Longevity Science / 18 September 2019
A small human study reports changes in senescent-cell burden
Mayo Clinic announced early clinical observations in people with diabetes-related kidney disease.
Read the analysis ↗LongevityGLEI / 2018
Longevity Science / 19 March 2018
A stem-cell-derived retinal patch enters clinical reporting
A phase 1 study reported a retinal pigment epithelium patch for severe age-related eye disease.
Read the analysis ↗